Healthcare and wellness company Nureka, listed just a month and a half ago in the stock market amid Corona’s second wave, has done wonders. During this period, it has given a return of 150 percent. On 25th February this year, the shares of this company were listed at a price of Rs 634.95 and today i.e. on 16th April (Friday) it got 10% upper circuit. In just a month and a half, its price has gone from Rs 634.95 to Rs 1,004.90.
Explain that Nureka’s Rs 100 crore IPO was opened from February 15 to 17 and was subscribed 39.93 times. During the financial year 2019-20, the company reported a revenue of Rs 99.48 crore and a profit of Rs 6.4 crore. Analysts expect strong results from the company in the March quarter. According to him, the company also supplies great products related to lifestyle, due to which its growth can be strong in the coming years. Analysts are advising investors to hold their positions instead of cashing profits.
This is a big reason for living
Due to the second wave of Corona, the demand for products like oximeter, thermometer, BP monitor, nebulizer has increased. Actually, Nureka makes similar products. The company supplies products in five categories – chronic devices, orthopedic, mother and child, nutrition and lifesite segments. This company has’ Dr. Trust ‘and’ Dr. There are brands like ‘Physio’.
We have taken all measures to ensure that the information provided in this article and on our social media platform is credible, verified and sourced from other Big media Houses. For any feedback or complaint, reach out to us at informalnewz@gmail.com
